| P2093 | author name string | N. Kobayashi | |
| | Y. Nakamura | |
| | S. Kato | |
| | H. Tsukamoto | |
| | T. Nishimura | |
| | T. Mitomi | |
| | M. Iwasawa | |
| | Y. Tokuda | |
| | S. Habu | |
| | M. Kidokoro | |
| P2860 | cites work | Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer | Q34194434 |
| | Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. | Q36346369 |
| | Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma | Q41293733 |
| | Bispecific Antibody-directed Antitumor Activity of Human CD4+Helper/Killer T Cells Induced by Anti-CD3 Monoclonal Antibody plus Interleukin 2 | Q41657844 |
| | Induction of cytotoxicity in human T cells coated with anti-glioma x anti-CD3 bispecific antibody against human glioma cells | Q41742682 |
| | Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response | Q41744259 |
| | Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype | Q41769462 |
| | Preliminary trial of specific targeting therapy against malignant glioma | Q41885657 |
| | A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product | Q42800730 |
| | Diet and gastric cancer. A case-control study in Belgium | Q43918500 |
| | Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells | Q46300243 |
| | Application of a human T cell line derived from a Sézary syndrome patient for human interleukin 4 assay. | Q52834144 |
| | Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2 | Q53553480 |
| | Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. | Q55483828 |
| | Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2 | Q63965639 |
| | Stimulation and inhibition of human T cell subsets by wheat germ agglutinin | Q67283648 |
| | Thymic stromal cell clone with nursing activity supports the growth and differentiation of murine CD4+8+ thymocytes in vitro | Q68163830 |
| | Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2 | Q68802643 |
| | Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies | Q68829463 |
| | Protein kinase C required for cytotoxic T lymphocyte triggering | Q68831195 |
| | Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells | Q69386256 |
| | A new high-yield continuous cell-culture system for lymphokine-activated killer cells | Q69404864 |
| | Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones | Q69809805 |
| | Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). I. Isolation and characterization | Q69936820 |
| | A new compact and cell dense continuous culture system | Q69965623 |
| | Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2 | Q70224204 |
| | Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres | Q70294369 |
| | Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells | Q70336391 |
| | In vivo generation of lymphokine-activated killer cells by sensitization with interleukin 2-producing syngeneic T-lymphoma cells | Q70378784 |
| | Differential requirements for activation and growth of unprimed cytotoxic and helper T lymphocytes | Q72794789 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| | adoptive immunotherapy | Q72138716 |
| P304 | page(s) | 20-26 | |
| P577 | publication date | 1992-07-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy | |
| P478 | volume | 66 | |